ArticleFrontiers in medicine2025
CausalX-Net: a causality-guided explainable segmentation network for brain tumors.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors represent a significant health challenge in India, with approximately 28,000 new cases diagnosed annually. Conventional deep learning approaches for MRI-based segmentation often struggle with irregular tumor boundaries, heterogeneous intensity patterns, and complex spatial relationships, resulting in limited clinical interpretability despite high numerical accuracy. This study introduces CausalX-Net, a causality-guided explainable segmentation network for brain tumor analysis from multi-modal MRI. Unlike purely correlation-based models, CausalX-Net leverages structural causal modeling and interventional reasoning to identify and quantify the causal influence of imaging features and spatial regions on segmentation outcomes. Through counterfactual analysis, the framework can provide clinically relevant "what-if" explanations, such as predicting changes in tumor classification if specific modalities, regions, or features are altered. Evaluated on the BraTS 2021 dataset, CausalX-Net achieved a Dice Similarity Coefficient of 92.5%, outperforming state-of-the-art CNN-based baselines by 4.3% while maintaining competitive inference efficiency. Furthermore, causal attribution maps and intervention-based sensitivity analyses enhance trust and transparency, offering radiologists actionable insights for diagnosis and treatment planning. This research demonstrates that integrating causal inference into segmentation not only improves accuracy but also delivers interpretable, decision-supportive explanations, representing a significant step toward transparent and reliable AI-assisted neuroimaging in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.